Comparison Between Standard Deep Anterior Lamellar Keratoplasty (S-DALK) and Intralase Enabled Deep Anterior Lamellar Keratoplaty (IE-DALK)

Sponsor
University of Toronto (Other)
Overall Status
Unknown status
CT.gov ID
NCT03732599
Collaborator
Kensington Eye Institute (Other), University Health Network, Toronto (Other), Unity Health Toronto (Other), Sunnybrook Health Sciences Centre (Other), Applied Health Research Centre (Other)
100
2
73.8

Study Details

Study Description

Brief Summary

A prospective comparison between standard deep anterior lamellar keratoplasty (S-DALK) performed manually using a blade (trephine) and femtosecond laser-enabled deep anterior lamellar keratoplasty (IE DALK), where incisions are performed using the femtosecond laser.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Standard Deep Anterior Keratoplasty (S-DALK)
  • Procedure: IE-DALK (femtosecond)
N/A

Detailed Description

Even though corneal transplants have been around for more than 100 years, and tools to improve their surgical technique keep getting perfected, both regular and irregular postoperative astigmatism continue to be major concerns in achieving predictable visual results. Femtosecond laser technology allows for the creation of more precise incisions with more reproducible patterns, which could lead us to believe that astigmatism management and visual results should be improved with this technology. This would be the first study to prospectively analyze standard versus femtosecond laser-enabled deep anterior lamellar keratoplasties in order to elucidate their relative advantages in the quest for a gold standard.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is a randomize study, in which half of the participants will be receiving either the standard deep anterior lamellar keratoplasty (DALK) (with a blade) technique or the femtosecond laser technique that creates the initial incisions instead of a blade.This is a randomize study, in which half of the participants will be receiving either the standard deep anterior lamellar keratoplasty (DALK) (with a blade) technique or the femtosecond laser technique that creates the initial incisions instead of a blade.
Masking:
Single (Care Provider)
Masking Description:
Technologists who do the vision testing on participants are "masked" as to which "arm" the participant was randomized
Primary Purpose:
Treatment
Official Title:
Comparison Between Standard Deep Anterior Lamellar Keratoplasty (S-DALK) and Intralase Enabled Deep Anterior Lamellar Keratoplaty (IE-DALK)
Actual Study Start Date :
Apr 8, 2015
Anticipated Primary Completion Date :
Dec 31, 2019
Anticipated Study Completion Date :
May 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard DALK

Standard (with the use of a blade) deep anterior lamellar keratoplasty (DALK), which is a partial thickness corneal transplant, which has been shown to be a safe and effective procedure.

Procedure: Standard Deep Anterior Keratoplasty (S-DALK)
Standard (with the use of a blade) deep anterior lamellar keratoplasty (DALK), which is a partial thickness corneal transplant, which has been shown to be a safe and effective procedure.

Active Comparator: IE-DALK (femtosecond)

Femtosecond deep anterior lamellar keratoplasty (DALK). The femotosecond laser technology allows for the creation of precise and reproducible corneal incisions.

Procedure: IE-DALK (femtosecond)
Femtosecond deep anterior lamellar keratoplasty (DALK). The femotosecond laser technology allows for the creation of precise and reproducible corneal incisions.

Outcome Measures

Primary Outcome Measures

  1. Change from preoperative topographical corneal astigmatism [preoperatively, 6, 12 and 15 months postoperatively]

    Corneal astigmatism is the difference (expressed in Diopter units) of refractive power between the steep and flat corneal meridians and is measured using corneal topography. Values range between 0 and 20 diopters. Lower values represent a better outcome.

Secondary Outcome Measures

  1. Change from preoperative best-corrected distance visual acuity (BCVA) [preoperatively, 6, 12 and 15 months postoperatively.]

    BCVA will be measured using an ETDRS acuity chart and recorded in logMAR (logarithm of the minimal angle of resolution) units. Value range is between -0.125 and 3 logMAR. Lower values represent a better outcome.

  2. Change from preoperative uncorrected distance visual acuity (UCVA) [preoperatively, 6, 12 and 15 months postoperatively.]

    UCVA will be measured using an ETDRS acuity chart and recorded in logMAR (logarithm of the minimal angle of resolution) units. Value range is between -0.125 and 3 logMAR. Lower values represent a better outcome.

  3. Big-bubble success rate [6 months postoperatively.]

    This outcome represents the number of procedures where the deep anterior lamellar keratoplasty (DALK) procedure was completed using the "big bubble" surgical technique. This can either be "Yes" for successful or "No" for unsuccessful completion of this technique. Higher big-bubble success rates represent a better outcome.

  4. Rate of conversion to penetrating keratoplasty [6 months postoperatively.]

    This outcome represents the number of failed DALK procedures (using any of the possible DALK techniques) that needed to be converted to a procedure other than DALK (a penetrating keratoplasty procedure). This can either be "Yes" for DALK failure and conversion to penetrating keratoplasty or "No" for a successful DALK procedure. Higher penetrating keratoplasty conversion rates represent a worse outcome.

  5. Change from preoperative endothelial cell count [preoperatively, 6, 12 and 15 months postoperatively.]

    This is the density of corneal endothelial cells (measured as cells per square millimeter). Value range is between 300 and 3500 cells/square millimeter. Higher values represent a better outcome.

  6. Change from preoperative pachymetry [preoperatively, 6, 12 and 15 months postoperatively.]

    This represents corneal thickness, measured in microns. Value ranges are between 200 and 800 microns. Values between 500 and 600 micron represents a good outcome.

  7. Change from preoperative higher-order optical aberrations [preoperatively, 6, 12 and 15 months postoperatively.]

    Values of total higher-order optical aberrations and coma higher-order optical aberration measured in RMS (root mean square) units. Value range is between -20 and +20 RMS. Lower absolute value represents a better outcome (values closer to zero on both the negative and positive ends).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age between 18 and 70 years

  • Either advanced keratoconus or corneal scarring requiring a deep anterior lamellar keratoplasty

Exclusion Criteria:
  • Previous keratoplasty

  • Advanced glaucoma

  • Any other retinal or optic nerve pathology that could potentially affect visual outcome

  • Strabismus or amblyopia

  • Significant limbal stem cell deficiency (invlolving > 3 limbal clock hours)

  • Active autoimmune disease.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Toronto
  • Kensington Eye Institute
  • University Health Network, Toronto
  • Unity Health Toronto
  • Sunnybrook Health Sciences Centre
  • Applied Health Research Centre

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Neera Singal, Director of Cornea and Refractive Surgery, Kensington Eye Institute
ClinicalTrials.gov Identifier:
NCT03732599
Other Study ID Numbers:
  • 30457
First Posted:
Nov 6, 2018
Last Update Posted:
Nov 27, 2018
Last Verified:
Nov 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 27, 2018